Home»Corporate Governance»Functional Committee»Audit Committee

Audit Committee

• 1. The Audit Committee held four committee meetings (A) in the most recent fiscal year, and the attendance of independent directors is tabulated below:

Position	Name	Attendance in Person (B)	Attendance Through Proxy	Attendance Rate (B/A) (%)	Remarks
Chairperson	Hung Ching Lee	4	0	100.0	Re-appointed on 2022/06/17
Committee Member	Dr. Pisin Chen	4	0	100.0	Re-appointed on 2022/06/17
Committee Member	Su-Pi Shen	2	0	100.0	Newly appointed on 2022/06/17

• On March 31, 2016, the board approved the “Audit Committee Charter” as a reference to establish the Audit Committee to supervise the fair expression of the Company’s financial statements, the selection or dismissal of certified public accountants (CPAs) and assessment of their independence and performance, effective implementation of the internal control, and legal compliance of the Company, as well as to control the inherent and potential risks.
• The 1^st Audit Committee was established on June 24, 2016 to replace the duties and functions of Supervisors. The Audit Committee consists of three independent directors as the ex officio members.
• Current Audit Committee marks the 3^rd term of office, and the Committee was re-elected to accompany the newly elected BoD on June 17, 2022. Three independent directors are elected as the Committee members, including Mr. Hung Ching Lee,
  Dr. Pisin Chen, and Ms. Su-Pi Shen. Mr. Hung Ching Lee and Ms. Su-Pi Shen both are equipped with professions in accounting or finance, while Mr. Hung Ching Lee was elected to convene the Committee and served as the Chairperson of Committee meetings. The tenure is for three years from June 17, 2022 to June 16, 2025, the same termination date as the end of the current BoD term.

• 2. Additional Disclosure:
• The date of the meeting, session, content of the motion, opinions expressed by all independent directors, and the Company’s response to such opinions shall be specified when the operation of Audit Committee is under any one of the following circumstances:
• • Matters specified in Article 14-3 of the Securities and Exchange Act:
• All independent directors had attended the audit committee meetings and approved all matters specified in Article 14-3 of the Securities and Exchange Act without objection in FY2022 and as of the date of annual report's publication.
• • Matters other than above stated which were not approved by the Audit Committee but resolved by over two thirds of all Directors: NA.
• • Execution of independent directors’ avoidance of motions in conflict of interests:
• No avoidance of motions in conflict of interests was reported.
• 3. Major resolutions resolved by the FY2023 Audit Committee:

Date of Resolution	Committee Term	Session	Summary of Resolution	Opinion of Independent Directors and Company’s Response
2023/03/15	2	3	Reported the status of performance evaluation on the Board of Directors and Functional Committees. Approved FY2022 financial statements. Approved CPA audit report of FY2022 financial statements. Approved the evaluation to adopt Audit Quality Indicators (AQI) for Audit Committees of TWSE listed companies. Approved the changes of certified accountants. Approved the allocation of FY2022 distributed earnings and business report of the year. Approved the effectiveness of evaluation and statement of internal control. Approved to setup a new firm in Mainland China through indirect investment of subsidiaries Approved cash donation to non-profit organizations. Approved the donation of notebooks to Quanta Arts Foundation.	Approved by all Independent Directors unanimously.
2023/04/17	2	4	Approved the establishment of subsidiary in Vietnam.	Approved by all Independent Directors unanimously.
2023/05/11	2	5	Reported on the implementation status of the Company's greenhouse gas inventory and verification schedule. Approved FY2023 Q1 financial statements. Approved CPA audit report of FY2022 Q1 financial statements. Approved donation to Quanta AI Medical Foundation.	Approved by all Independent Directors unanimously.
2023/08/11	2	6	Report on the implementation status of the Company's greenhouse gas inventory and verification schedule. Approved FY2023 Q2 financial statements. Approved CPA audit report of FY2022 Q2 financial statements. Resolved not to distribute dividends for 1H of FY2023. Resolved to subscribe to cash capital increase of QMN through indirect investment. Resolved to subscribe to cash capital increase of QCG through indirect investment. Approved the application of syndicated loan facility with financial institutes. Ratified sales of machinery equipment to subsidiary.	Approved by all Independent Directors unanimously.
2023/11/10	2	7	Reported on the implementation status of the Company's greenhouse gas inventory and verification schedule. Approved FY2022 Q3 financial statements. Approved CPA audit report of FY2022 Q3 financial statements. Approved donation to Quanta Culture & Education Foundation. Approved the application of extending syndicated loan facility and changes in agreement terms with financial institutes.	Approved by all Independent Directors unanimously.
2023/12/20	2	8	Reported on the operation and the implementation status of sustainable development, including the implementation of the Company's greenhouse gas inventory and verification schedule for the current year, and the operation status of promoting ethical corporate management. Approved the annual assessment of the independence and competency of the accountant and the proposal to establish the general principles of the Company's pre-approved non-assurance services policy. Approved the evaluation to adopt Audit Quality Indicators (AQI) for Audit Commitees of TWSE listed companies. Approved the establishment of the Company’s “Rules Governing Financial and Business Matters Between this Corporation and its Affiliated Enterprises”. Approved donation to Quanta Arts Foundation. Approved donation to IBMI.	Approved by all Independent Directors unanimously.

Audit Committee Charter

• https://www.quantatw.com/Quanta/english/corporategovernance/ruleandinfo.aspx